SCHEMBL276675

SCHEMBL276675

O=[C]CCC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.59
MAPT P10636 3/20 0.59
LMNA P02545 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
NR4A2 P43354 1/20 0.59
MAPK1 P28482 3/20 0.54
KMT2A Q03164 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MEN1 O00255 1/20 0.54
CYP3A4 P08684 1/20 0.54
HPGD P15428 1/20 0.54
ALOX15 P16050 1/20 0.54
CES1 P23141 1/20 0.54
HDAC1 Q13547 5/20 0.53
HDAC8 Q9BY41 5/20 0.53
ALDH1A1 P00352 3/20 0.53
GAA P10253 1/20 0.53
CYP2C19 P33261 1/20 0.53
HDAC3 O15379 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035615 0.88 TDP1 (0.67) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL10457866 0.84 TDP1 (0.74) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL12989353 0.84 TDP1 (0.74) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL8153235 0.84 TDP1 (0.74) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL2240191 0.84 TDP1 (0.74) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL719034 0.81 NR4A2 (0.85) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL30121738 0.81 NR4A2 (0.85) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL10556922 0.81 TDP1 (0.57) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL8575630 0.81 TDP1 (0.57) TDP1MAPTLMNAL3MBTL1NR4A2
SCHEMBL1941975 0.81 TDP1 (0.57) TDP1MAPTLMNAL3MBTL1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090300800-A1 D-Amino Acid a Selectable Marker for Barley (Hordeum Vulgare L.) Transformation BASF PLANT SCIENCE GMBH (DE) 2009-12-03 US claimed
US-20070248996-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids PARAECIS PHARMACEUTICALS, INC. (US) 2007-10-25 US claimed
US-20060014696-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids PRAECIS PHARMACEUTICALS, INC. (US) 2006-01-19 US claimed
EP-0929574-B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARM INC (US) 2005-06-29 EP claimed
EP-0898575-B1 A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES KOESTER HUBERT DR (US) 2004-12-29 EP claimed
US-6828435-B2 Three blocking groups are independently removable under 3 different conditions; using new protection schemes and solid phase synthesis, oligonucleotides are obtained in 5' to 3' direction using phosphoamidites and avoiding depurination HK PHARMACEUTICALS, INC. 2004-12-07 US claimed
EP-1126833-A4 OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF TREGA BIOSCIENCES INC (US) 2004-09-08 EP claimed
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof CHATTOPADHYAYA JYOTI (SE) 2004-07-22 US claimed
EP-0679196-B1 DNA SEQUENCING BY MASS SPECTROMETRY SEQUENOM INC (US) 2004-05-26 EP claimed
US-20030194741-A1 COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES CAPROTEC BIOANALYTICS GMBH (DE) 2003-10-16 US claimed
EP-0679196-A1 DNA SEQUENCING BY MASS SPECTROMETRY SEQUENOM, INC. (US) 1995-11-02 EP claimed
EP-0648220-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA, Jyoti (SE) 1995-04-19 EP claimed
EP-0456514-B1 2-Fluoroneplanocin A and its production ASAHI CHEMICAL IND (JP) 1994-10-19 EP claimed
WO-1994016101-A2 DNA SEQUENCING BY MASS SPECTROMETRY KOESTER HUBERT (US) 1994-07-21 WO claimed
WO-1994010128-A1 NOVEL PHOTOREACTIVE PROTECTING GROUPS AFFYMAX TECHNOLOGIES N.V. (AN) 1994-05-11 WO claimed
US-5279818-A Permanent waving with silicones DOW CORNING CORPORATION (US) 1994-01-18 US claimed
WO-1993025566-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA JYOTI (SE) 1993-12-23 WO claimed
WO-1992011276-A1 NOVEL SYNTHESIS OF 2'-'UP' FLUORINATED 2''-DEOXY-ARABINOFURANOSYLPURINES SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1992-07-09 WO claimed
EP-0456514-A1 2-Fluoroneplanocin A and its production ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1991-11-13 EP claimed
US-4495346-A CATALYTICALLY COUPLING TWO MONOSACCHARIDES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1985-01-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070248996-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids APP, IAPP, BACE1 TDP1 1980/4885MAPT 121/4885LMNA 1617/4885
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof RNASEH1, RNASEL, NSUN2 TDP1 99/4885MAPT 4857/4885LMNA 384/4885
US-20030194741-A1 COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES ADAR, RNMT, ATIC TDP1 3076/4885MAPT 2388/4885LMNA 2407/4885
US-20060014696-A1 Modulators of beta-amyloid peptide aggregation comprising D-amino acids APP, IAPP, BACE1 TDP1 1980/4885MAPT 121/4885LMNA 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.